NeoPharm Co., Ltd. (092730) Price & Analysis

― Followers

092730 Stock Chart & Stats

₩22550.00

-₩500.00(-2.17%)

Aug 21, 2026

―

Day’s Range― - ―

52-Week Range₩15,590.00 - ₩26,000.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)49.12K

Market Cap

₩360.53B

Enterprise Value₩141.49K

Total Cash (Recent Filing)₩147.59B

Total Debt (Recent Filing)₩1.65B

Price to Earnings (P/E)6.1

Beta0.14

Next Earnings

Nov 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1873.90

Shares Outstanding16,027,988

10 Day Avg. Volume51,982

30 Day Avg. Volume49,122

Financial Highlights & Ratios

PEG Ratio0.32

Price to Book (P/B)0.93

Price to Sales (P/S)1.38

P/FCF Ratio6.70

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)1,928

Revenue Forecast (FY)₩160.30B

092730 FAQ

What was NeoPharm Co., Ltd.’s price range in the past 12 months?

NeoPharm Co., Ltd. lowest stock price was ₩15590.00 and its highest was ₩26000.00 in the past 12 months.

What is NeoPharm Co., Ltd.’s market cap?

NeoPharm Co., Ltd.’s market cap is ₩360.53B.

When is NeoPharm Co., Ltd.’s upcoming earnings report date?

NeoPharm Co., Ltd.’s upcoming earnings report date is Nov 06, 2026 which is in 75 days.

How were NeoPharm Co., Ltd.’s earnings last quarter?

NeoPharm Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩537.374 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is NeoPharm Co., Ltd. overvalued?

According to Wall Street analysts NeoPharm Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does NeoPharm Co., Ltd. pay dividends?

NeoPharm Co., Ltd. pays a N/A dividend of ₩750 which represents an annual dividend yield of N/A. See more information on NeoPharm Co., Ltd. dividends here

What is NeoPharm Co., Ltd.’s EPS estimate?

NeoPharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NeoPharm Co., Ltd. have?

NeoPharm Co., Ltd. has 16,027,988 shares outstanding.

What happened to NeoPharm Co., Ltd.’s price movement after its last earnings report?

NeoPharm Co., Ltd. reported an EPS of ₩537.374 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.615%.

Which hedge fund is a major shareholder of NeoPharm Co., Ltd.?

Currently, no hedge funds are holding shares in KR:092730

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NeoPharm Co., Ltd.

NeoPharm Co., Ltd. focuses on the invention, manufacturing, and distribution of various cosmetic, medical, and health-related goods. Their product line features advanced emulsified and specialized skincare solutions, particularly designed for individuals with sensitive or dry skin. Additionally, the company provides treatments for ailments like atopic dermatitis and psoriasis, alongside therapies aimed at mitigating the side effects of steroid use. Established on July 1, 2000, the firm's main office is situated in Daejeon, South Korea.